Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Medidata Solutions (MDSO) Sees Rating Drop….. Eroding Quant Score

Portfolio Grader currently ranks Medidata Solutions (NASDAQ:MDSO) a Hold. The methodology for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

VWR Corp (VWR) a Hold on Uninspiring Earnings Momentum

VWR Corp (NASDAQ:VWR) ranks in the upper half of its industry group, Life Sciences Tools & Services, and in the top quarter of its sector group, Health Care, with a market value of $4.4 billion. From an investment attractiveness prospective, VWR is ranked in the top half of the sector with a ranking of 266 among the 785 companies in the sector; The current Portfolio Grader ranking for VWR puts it 19 among the 33 companies in this industry group, which is a below-average position and number 1,720 in the 5000 company Portfolio Grader company universe.

Robust Earnings Momentum Metrics Drive Upgrade of Bio-Techne (TECH) to Buy

Portfolio Grader currently ranks Bio-Techne Corp (NASDAQ:TECH) a Buy. Using Louis Navellier's investing approach, this analytical tool evaluates stocks by employing proprietary fundamental and quantitative analytical tools. The shares have been upgraded from a Hold to a Buy in the last week.

Why the Big Rally In Roku Inc Stock Is Overdone

ROKU stock is up big after blowout earnings, but one good report for Roku doesn't eliminate mounting competition concerns.

6 Stocks Dragging the Stock Market Down

Stocks suffer their worst pullback in months on Thursday, with the Dow giving back more than 200 points tax cut legislation concerns.

Rating on athenahealth (ATHN) Raised to Buy From a Hold

Portfolio Grader currently ranks athenahealth Inc (NASDAQ:ATHN) a Buy. The methods for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Excellent Earnings Visibility Metrics Drive Upgrade of PRA Health Sciences (PRAH) to Strong Buy

PRA Health Sciences Inc (NASDAQ:PRAH) is ranked as a Strong Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Oprah’s Loss Is Weight Watchers International, Inc. Stock’s Gain

WTW stock has increased by more than 7 times over the past 2 years, but the Weight Watchers International, Inc. rally isn't done yet.

Bruker (BRKR) a Buy on Strong Quant Score

Bruker Corp (NASDAQ:BRKR) is classified as a component of the 33 company Life Sciences Tools & Services GICS industry group, which is part of the 785 company GICS Health Care sector. BRKR's market value is $5.3 billion which falls in the upper half of its industry group. The ranking for BRKR by Portfolio Grader places it 9 among the 33 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 98 among the 785 companies in the sector, and number 641 in the nearly 5,000 company Portfolio Grader universe.

Commanding Earnings Momentum Metrics Raise Ranking of Charles River Labs (CRL) to Strong Buy

Charles River Labs (NYSE:CRL) is ranked as a Strong Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. CRL has been upgraded from a Buy to a Strong Buy in the last week.

Earnings Growth Analytics Power Icon (ICLR) to Strong Buy

As one of the 785 companies in the GICS Health Care sector Icon Plc (NASDAQ:ICLR) is a component of the 33 company Life Sciences Tools & Services GICS industry group within this sector. ICLR's market value is $6.7 billion which places it in the top half of its industry group. Currently, the stock's Portfolio Grader ranking places it 4 among the 33 companies in this industry group, giving it a well above-average position; among the sector leaders with a ranking of 23 among the 785 companies in the sector, and number 186 in the nearly 5,000 company Portfolio Grader universe.

Rating for Qiagen NV (QGEN) Drops….. Weak Industry Group Rank

Qiagen NV (NASDAQ:QGEN) is one of 33 companies within the Life Sciences Tools & Services GICS industry group, which is in turn part of the 785 company GICS Health Care sector. QGEN has a market value of $7.7 billion which is in the top half of its industry group. The ranking for QGEN by Portfolio Grader places it 21 among the 33 companies in this industry group, giving it a lower than average position; in the top half of the sector with a ranking of 338 among the 785 companies in the sector, and number 2,179 in the nearly 5,000 company Portfolio Grader universe.

Rating on Bio Rad Laboratories (BIO) Raised to Strong Buy From a Buy

Currently, Bio Rad Laboratories Inc (NYSE:BIO) has a Strong Buy using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. BIO has been upgraded from a Buy to a Strong Buy in the last week.

Earnings Momentum Keep PerkinElmer (PKI) a Buy

PerkinElmer Inc (NYSE:PKI) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methods. PKI has maintained this ranking for the last month.

Veeva Systems (VEEV) a Buy on Robust Earnings Momentum

As one of the 785 companies in the GICS Health Care sector Veeva Systems Inc (NYSE:VEEV) is a component of the 24 company Health Care Technology GICS industry group within this sector. VEEV's market value is $8.7 billion which falls in the top decile in its industry group. The ranking for VEEV by Portfolio Grader places it 6 among the 24 companies in this industry group, putting it in the second quartile; in the top quartile of the sector with a ranking of 112 among the 785 companies in the sector, and number 708 in the nearly 5,000 company Portfolio Grader universe.

Metrics for Quant Score Drive Upgrade of Waters (WAT) to Buy

With a $15.7 billion market value, Waters Corp (NYSE:WAT) ranks in the top quarter of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, in market value. From the prospective of investment attractiveness, Portfolio Grader's current ranking for WAT puts it 10 among the 33 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 107 among the 785 companies in the sector, and number 683 in the nearly 5,000 company Portfolio Grader universe.

Outstanding Quant Score Makes Mettler-Toledo International (MTD) a Strong Buy

As one of the 785 companies in the GICS Health Care sector Mettler-Toledo International Inc (NYSE:MTD) is a component of the 33 company Life Sciences Tools & Services GICS industry group within this sector. MTD has a market value of $16.5 billion which is in the top 25% of its industry group. Portfolio Grader's current ranking for MTD puts it 5 among the 33 companies in this industry group, putting in the top quartile; among the sector leaders with a ranking of 35 among the 785 companies in the sector, and number 256 in the nearly 5,000 company Portfolio Grader universe.

Cerner (CERN) a Buy on Solid Quant Score

Portfolio Grader currently ranks Cerner Corp (NASDAQ:CERN) a Buy. Using Louis Navellier's investing methods, this analytical tool researches stocks by employing proprietary fundamental and quantitative metrics. CERN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Best-in-Class Metrics for Earnings Momentum Make Agilent Technologies (A) a Strong Buy

Agilent Technologies Inc (NYSE:A) is one of the 785 companies in the GICS Health Care sector, and a component of the 33 company Life Sciences Tools & Services GICS industry group within this sector. A has a market value of $22.0 billion which is in the top 25% of its industry group. Portfolio Grader's current ranking for A puts it 7 among the 33 companies in this industry group, giving it a well above-average position; among the sector leaders with a ranking of 63 among the 785 companies in the sector, and number 438 in the nearly 5,000 company Portfolio Grader universe.